Sentiment Survey
|
|
|
|
|
|
|
|
|
|
|
|
Investment Grade:
|
|
Comments(0)
|
(0)
|
(0)
|
Ranking History
Headlines
- Health Cost Containment Index: Expanding Into India, Impax Labs Set to Re-List
Nov 27, 2008 12:55 AM
- Stantec Inc. - Aggressive Growth - Zacks Rank Buy
Nov 04, 2008 09:57 AM
- NASDAQ Technical Picture - 50 SMA holds as Support
Jun 10, 2008 02:52 AM
- Stantec To Buy McIntosh Engineering; No Terms
May 14, 2008 09:52 AM
- Stantec 1Q Earnings Improve On Higher Revenue
May 01, 2008 10:13 AM
- Stantec Increases Credit Facility To C$250 Million
Jan 23, 2008 09:53 AM
- Market Commentary
Aug 13, 2007 04:59 PM
- IPO REPORT: Tech Deals Wade Into Market After Choppy Year
Sep 11, 2006 01:58 PM
- Emergis, Systems Xcellence Safe Software Bets: Analyst
Jun 16, 2006 03:28 PM
- SXC Health Solutions to host analyst and institutional investor event
Nov 11, 2008 10:01 AM
- SXC Health Solutions to host analyst and institutional investor event
Nov 11, 2008 10:00 AM
- SXC Health Solutions to present at the Oppenheimer & Co. 4th Annual Mid and Small Cap 'Best Ideas' Conference
Nov 07, 2008 09:03 AM
- SXC Health Solutions announces third quarter financial results
Nov 06, 2008 06:02 AM
- SXC Health Solutions announces third quarter financial results
Nov 06, 2008 06:00 AM
- SXC Health Solutions to present at the 2008 Annual Credit Suisse Healthcare Conference
Nov 03, 2008 04:00 PM
- SXC Health Solutions announces PBM services agreement with Health Plan of San Mateo
Nov 03, 2008 08:36 AM
- SXC Health Solutions announces PBM services agreement with Health Plan of San Mateo
Nov 03, 2008 08:35 AM
- SXC Health Solutions to Host Fiscal 2008 Third Quarter Financial Results Conference Call
Oct 15, 2008 08:15 AM
- SXC Health Solutions to Host Fiscal 2008 Third Quarter Financial Results Conference Call
Oct 15, 2008 08:15 AM
Analyst Ratings
|
|
Share Performance
|
Period
|
SXC
|
Compare to S&P
|
| YTD |
-41.34 %
|
-29.93 %
|
| 4 Weeks |
-9.92 %
|
-8.37 %
|
| 12 Weeks |
-23.98 %
|
-14.65 %
|
|
Financial Ratios
Earnings Performance
|
EPS Growth in Last Quarter: -11.90 %
|
|
EPS Growth in Last Year: 23.33 %
|
|
Sales Growth in Last Quarter: 15.15 %
|
|
Sales Growth in Last Quarter: 54.53 %
|
|
|
